Skip to main content


GPAS: Uniting global data
to reach global solutions


How can we stop the spread?

Two years into the SARS-CoV-2 pandemic, emerging variants of concern (VOC) are jeopardising global recovery. Unlocking genomic insight requires expertise and access to high-performance computing, and sharing data across borders needs a highly secure digital environment (and patience, and trust). The necessary infrastructure and operational support are not evenly distributed – and are not always where they are needed. Sequencing information is often unattainable, slow to process or is stored in isolated pockets, leaving scientists and governments working in silos.

Standardised, rapid and secure analysis

The Global Pathogen Analysis System (GPAS) is run by a not-for-profit entity, offering a global turnkey solution that standardises how genomic sequence data is processed. This solution is offered free at the point of use for academic and research labs in low-and-middle income countries, with operational costs being covered by willing governments and major health organisations by agreement.

The secure, cloud-based system can analyse and translate data to give users an instant global perspective on their findings whilst maintaining full ownership and control by protecting personal identifiable information (PII). It can also integrate with sequencing infrastructures and data repositories that already exist for seamless tracking.

Watch the video to learn more from our solution experts – Oxford University’s Professor Derrick Crook, Professor of Microbiology and Professor Sir John Bell, immunologist and geneticist.

The GPAS project team

How GPAS enables early detection and study

GPAS is the first fully automated, real-time picture of pathogen dynamics. It will facilitate better tracking and management of diseases and VOCs worldwide to ensure a fast and effective response. This includes an early warning system to track the spread of variants in real time. GPAS’ services are cloud-based and secure which alleviates any current issues with worldwide genomic sequencing through:



Near instantaneous updates, rapid sequence processing.



In-built computational infrastructure, labs not required to build their own.



Personally identifiable information (PII) is removed. Data shared at your discretion.



More countries can track variants online and take action.

Get in touch

Contact us for demos and more detailed information on the solution. We are also interested in exploring further opportunities for partnership.